Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations
- 30 September 2004
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 24 (5) , 388-399
- https://doi.org/10.1002/humu.20097
Abstract
A subtype of phenylalanine hydroxylase (PAH) deficiency that responds to cofactor (tetrahydrobiopterin, BH4) supplementation has been associated with phenylketonuria (PKU) mutations. The underlying molecular mechanism of this responsiveness is as yet unknown and requires a detailed in vitro expression analysis of the associated mutations. With this aim, we optimized the analysis of the kinetic and cofactor binding properties in recombinant human PAH and in seven mild PKU mutations, i.e., c.194T>C (p.I65T), c.204A>T (p.R68S), c.731C>T (p.P244L), c.782G>A (p.R261Q), c.926C>T (p.A309V), c.1162G>A (p.V388M), and c.1162G>A (p.Y414C) expressed in E. coli. For p.I65T, p.R68S, and p.R261Q, we could in addition study the equilibrium binding of BH4 to the tetrameric forms by isothermal titration calorimetry (ITC). All the mutations resulted in catalytic defects, and p.I65T, p.R68S, p.P244L, and most probably p.A309V, showed reduced binding affinity for BH4. The possible stabilizing effect of the cofactor was explored using a cell‐free in vitro synthesis assay combined with pulse‐chase methodology. BH4 prevents the degradation of the proteins of folding variants p.A309V, p.V388M, and p.Y414C, acting as a chemical chaperone. In addition, for wild‐type PAH and all mild PKU mutants analyzed in this study, BH4 increases the PAH activity of the synthesized protein and protects from the rapid inactivation observed in vitro. Catalase and superoxide dismutase partially mimic this protection. All together, our results indicate that the response to BH4 substitution therapy by PKU mutations may have a multifactorial basis. Both effects of BH4 on PAH, i.e., the chemical chaperone effect preventing protein misfolding and the protection from inactivation, may be relevant mechanisms of the responsive phenotype. Hum Mutat 24:388–399, 2004.Keywords
Funding Information
- Ministerio de Sanidad y Consumo (REDEMETH G03/054, PI020117)
- Comisión Interministerial de Ciencia y Tecnología, Spain (SAF2001-0544)
- Research Council of Norway
This publication has 35 references indexed in Scilit:
- Ferrous Ion Binding to Recombinant Human H-Chain Ferritin. An Isothermal Titration Calorimetry StudyBiochemistry, 2002
- Crystal Structure of the Ternary Complex of the Catalytic Domain of Human Phenylalanine Hydroxylase with Tetrahydrobiopterin and 3-(2-Thienyl)-l-alanine, and its Implications for the Mechanism of Catalysis and Substrate ActivationJournal of Molecular Biology, 2002
- High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphismsThe American Journal of Clinical Nutrition, 2002
- A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuriaJournal of Inherited Metabolic Disease, 2001
- Partial characterization and three‐dimensional‐structural localization of eight mutations in exon 7 of the human phenylalanine hydroxylase gene associated with phenylketonuriaEuropean Journal of Biochemistry, 1998
- Structure of Tetrameric Human Phenylalanine Hydroxylase and Its Implications for PhenylketonuriaJournal of Biological Chemistry, 1998
- Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuriaNature Structural & Molecular Biology, 1997
- Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactionsChemistry & Biology, 1995
- Tetrahydrobiopterin Deficiency: From Phenotype to GenotypePteridines, 1993
- The auto‐oxidation of tetrahydrobiopterinEuropean Journal of Biochemistry, 1988